Skip to main content

GSA Logo High Res No Background (1) (2)-1

 

    MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma

    MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma

    Click HERE to view the article on Yahoo.

    Pediatric Malignancies: Medulloblastoma

    Click HERE to view the article on Emergency Live.

    Hedgehog Pathway Inhibitors Market Size Trends Insights | Japan | China | 2022

    Click HERE to view the article on OpenPR.

    Advice from Harvard Health Publishing: What causes basal cell carcinoma?

    Click HERE to view this article on MSN.com.

    Hedgehog Pathway Inhibitors Market to Expand at a Notable CAGR of ~11.1% Assessment for the Driving Factors, Size, Revenue, Segments, Expansion, Demand, and Opportunities During 2023-2033

    Click HERE to view the article on Digital Journal.

    Use of JAK Inhibitors in Clinical Practice

    Click HERE to view the article on Dermatology Times.

    Cutaneous Horn: A Masquerade to Underlying Keratotic Basal Cell Carcinoma

    Click HERE to view the article on Cureus.

    The Chemoprotective Role of Vitamin D in Skin Cancer: A Systematic Review

    Click HERE to view the article on Dovepress.

    UV Protection from Window Tinting

    UV Protection from Window Tinting

    Using Dermoscopy in Skin of Color to Differentiate Pigmented Lesions From Skin Cancer

    Click HERE to view the article on Dermatology Times.